CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 157 filers reported holding CLOVIS ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $2,000 | -97.1% | 1,752 | -95.4% | 0.00% | – |
Q2 2022 | $68,000 | -82.2% | 37,715 | -80.0% | 0.00% | – |
Q1 2022 | $382,000 | -86.2% | 188,919 | -81.5% | 0.00% | -100.0% |
Q4 2021 | $2,765,000 | +33.8% | 1,020,351 | +120.2% | 0.00% | 0.0% |
Q3 2021 | $2,066,000 | -48.4% | 463,330 | -32.8% | 0.00% | -50.0% |
Q2 2021 | $4,001,000 | -17.3% | 689,759 | +0.1% | 0.00% | -33.3% |
Q1 2021 | $4,839,000 | +373.0% | 689,258 | +223.4% | 0.00% | – |
Q4 2020 | $1,023,000 | -23.7% | 213,104 | -7.3% | 0.00% | – |
Q3 2020 | $1,340,000 | -39.1% | 229,846 | -29.5% | 0.00% | -100.0% |
Q2 2020 | $2,201,000 | +39.7% | 325,936 | +31.7% | 0.00% | 0.0% |
Q1 2020 | $1,575,000 | -48.4% | 247,557 | -15.4% | 0.00% | -66.7% |
Q4 2019 | $3,051,000 | +279.5% | 292,596 | +43.1% | 0.00% | – |
Q3 2019 | $804,000 | -88.1% | 204,480 | -55.0% | 0.00% | -100.0% |
Q2 2019 | $6,761,000 | +247.6% | 454,702 | +480.3% | 0.01% | +200.0% |
Q1 2019 | $1,945,000 | -74.6% | 78,355 | -81.6% | 0.00% | -75.0% |
Q4 2018 | $7,656,000 | +73.6% | 426,301 | +183.8% | 0.01% | +100.0% |
Q3 2018 | $4,411,000 | +67.8% | 150,191 | +159.7% | 0.00% | +100.0% |
Q2 2018 | $2,629,000 | -73.8% | 57,828 | -69.6% | 0.00% | -77.8% |
Q1 2018 | $10,049,000 | +6.4% | 190,324 | +37.0% | 0.01% | +28.6% |
Q4 2017 | $9,448,000 | -69.5% | 138,943 | -63.1% | 0.01% | -72.0% |
Q3 2017 | $30,988,000 | -9.3% | 376,073 | +3.1% | 0.02% | -19.4% |
Q2 2017 | $34,150,000 | +9.2% | 364,743 | -25.7% | 0.03% | +14.8% |
Q1 2017 | $31,261,000 | +137.7% | 490,999 | +65.9% | 0.03% | +125.0% |
Q4 2016 | $13,150,000 | +363.5% | 296,042 | +276.1% | 0.01% | +300.0% |
Q3 2016 | $2,837,000 | +839.4% | 78,715 | +258.7% | 0.00% | – |
Q2 2016 | $302,000 | -88.9% | 21,942 | -84.5% | 0.00% | -100.0% |
Q1 2016 | $2,718,000 | -22.5% | 141,577 | +41.4% | 0.00% | 0.0% |
Q4 2015 | $3,505,000 | -75.6% | 100,155 | -35.8% | 0.00% | -78.6% |
Q3 2015 | $14,347,000 | +246.4% | 156,012 | +230.9% | 0.01% | +250.0% |
Q2 2015 | $4,142,000 | +64.7% | 47,141 | +39.2% | 0.00% | +100.0% |
Q1 2015 | $2,515,000 | +93.3% | 33,875 | +45.8% | 0.00% | +100.0% |
Q4 2014 | $1,301,000 | +29.3% | 23,231 | +4.8% | 0.00% | 0.0% |
Q3 2014 | $1,006,000 | +54.8% | 22,166 | +41.2% | 0.00% | – |
Q2 2014 | $650,000 | +13.4% | 15,699 | +89.4% | 0.00% | -100.0% |
Q1 2014 | $573,000 | -12.9% | 8,288 | -24.0% | 0.00% | 0.0% |
Q4 2013 | $658,000 | +0.9% | 10,902 | +1.7% | 0.00% | 0.0% |
Q3 2013 | $652,000 | +3004.8% | 10,715 | +3269.5% | 0.00% | – |
Q2 2013 | $21,000 | – | 318 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |